A phase II, pharmacokinetic (PK) and biological correlative study of OSI-774 (Tarceva) in patients with advanced renal cell carcinoma, with FDG-PET imaging : evidence of durable stable disease and antitumor activity

• BEERAM M

収録刊行物

• Eur J Cancer Suppl

  Eur J Cancer Suppl 2 111-, 2005

詳細情報

• CRID: 1570572700432896768
• NII論文ID: 10018174478
• データソース種別:
  • CiNii Articles